X0609 4 2026-09-18 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0002112339 Savage Brian true C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A STREET TEL AVIV L3 6944020 ISRAEL false true false false Interim Chief Legal Officer false Ordinary Shares 2026-09-18 4 M false 4503 34.7 A 15842 D Ordinary Shares 2026-09-18 4 S false 4503 38.69 D 11339 D Ordinary Shares 2026-09-18 4 S false 2525 39.145 D 8814 D Ordinary Shares 2026-09-18 4 S false 314 38.7038 D 8500 D Stock Options (right to buy) 34.7 2026-09-18 4 M false 4503 34.7 D 2027-03-03 Ordinary Shares 4503 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.14 to $39.155, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Stock options were granted on March 3, 2017, with 1,125 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,128 vested on March 3, 2021. /s/ Dov Bergwerk as attorney-in-fact for Brian P. Savage 2026-09-22